Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Lung Cancer Screening Market Expansion From $3.65 Billion In 2026 To $5.24 Billion In 2030

Throughout recent history, the lung cancer screening market has experienced robust expansion, projecting a rise from $3.33 billion in 2025 to $3.65 billion in 2026, marking a compound annual growth rate of 9.6%. This historical growth trajectory has been significantly influenced by a confluence of factors including the escalating rates of lung cancer within aging demographics, a heightened public understanding of the advantages associated with early detection through screening, the broadening availability of diagnostic imaging facilities, advancements in CT imaging technology, and the consistent implementation of screening guidelines.

The market for lung cancer screening is poised for substantial expansion in the coming years, projected to reach $5.24 billion by 2030, reflecting a compound annual growth rate of 9.5%. This anticipated growth during the forecast period is driven by several key factors, including the widening use of AI-enhanced diagnostic processes, a broader rollout of population-wide screening initiatives, a heightened emphasis on individualized risk evaluations, increased financial backing for technologies aimed at early cancer detection, and augmented governmental healthcare policies that endorse screening practices. Prominent trends expected to shape this market over the forecast period encompass a greater uptake of low-dose CT screening programs, a more significant incorporation of artificial intelligence in interpreting medical images, a concentrated effort on screening high-risk demographics, the expansion of proactive oncology efforts, and a reinforced commitment to identifying lung cancer in its earliest stages.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

Lung Cancer Screening Market Demand Drivers Creating New Revenue Opportunities

An increase in smoking prevalence is anticipated to fuel the expansion of the lung cancer screening market. Smoking, characterized by the inhalation of smoke from burning materials, commonly tobacco, into the mouth and lungs, is becoming more common as individuals grapple with escalating stress levels and utilize it as a method for coping. Lung cancer screening plays a crucial role in mitigating the impact of rising smoking rates by facilitating the early identification of health issues linked to smoking, thereby encouraging cessation and contributing to public health initiatives aimed at curbing tobacco consumption. As an illustration, data from October 2024 revealed that the Office for Health Improvement & Disparities in the UK reported 19.5% of individuals in routine and manual occupations (aged 18-64) were current smokers in 2023. This upward trend in smoking directly correlates with the projected growth within the lung cancer screening market.

Lung Cancer Screening Market Segmentation And Category Breakdown

The lung cancer screening market covered in this report is segmented –

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

Lung Cancer Screening Market Trends Driving Strategic Industry Expansion

Within the lung cancer screening sector, prominent entities are concentrating their efforts on creating sophisticated capabilities, such as “normal flagging,” to elevate the precision of diagnoses, mitigate incorrect positive results, and bolster the early identification of cancerous nodules. Normal flagging is essentially a safety mechanism within lung cancer screening systems that automatically identifies scans showing no concerning signs, thereby streamlining the process of focusing on cases that warrant additional scrutiny. As an illustration, in May 2025, Lunit Inc., a medical technology firm hailing from South Korea, unveiled INSIGHT CXR4, its cutting-edge AI-driven system for analyzing chest X-rays, which has since obtained CE MDR certification for implementation throughout Europe. This system, engineered to aid radiologists by enhancing diagnostic precision and operational speed, is capable of identifying a dozen different chest conditions, including lung nodules, pneumonia, and acute bone fractures, and incorporates functionalities like comparing current and previous images to aid in the early detection of disease and informed clinical judgments.

Lung Cancer Screening Market Competitive Analysis Of Major Industry Participants

Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation

Access The Complete Lung Cancer Screening Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

Lung Cancer Screening Market Regional Analysis And Leading Geography

North Americawas the largest region in the lung cancer screening market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model